GOG 0218 PDF

GOG randomized, double-blind, placebo-controlled phase III trial: (A) study design; (B) progression-free survival analysis (reproduced with permission) Download scientific diagram | Design of Study GOG from publication: Time for a Level Playing Field: Inequalities in Regulatory/Approval Processes–The. ASCO Annual Meeting CHICAGO — The addition of bevacizumab as maintenance therapy to first-line treatment with standard.

Author: Barr Brarn
Country: Russian Federation
Language: English (Spanish)
Genre: Literature
Published (Last): 20 August 2018
Pages: 363
PDF File Size: 2.34 Mb
ePub File Size: 12.32 Mb
ISBN: 955-8-13773-175-3
Downloads: 31461
Price: Free* [*Free Regsitration Required]
Uploader: Dorisar

Bevacizumab Approved by FDA to Treat Ovarian Cancer Following Surgery

Avastin, in gkg with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy, is indicated for the second-line treatment of patients with metastatic colorectal cancer who have progressed on a first-line Avastin-containing regimen.

Persistent, recurrent, or metastatic cervical cancer CC Avastin, in combination with paclitaxel and cisplatin or paclitaxel and topotecan, is indicated for the treatment of patients with persistent, recurrent, or metastatic cervical cancer.

Overview of proposed MOA of Avastin. The GOG study evaluated Avastin plus chemotherapy vs chemotherapy alone in platinum-sensitive ovarian cancer [ 1,3 ]. Prescribing Information Register for Updates References. PFS data are based on investigator assessment.

Efficacy data overview [1]. Additional serious adverse events Additional serious and sometimes fatal adverse events with increased incidence in the Avastin-treated arm vs chemotherapy arm included: You may also report side effects to Genentech at These data are likely to underestimate the true adverse event rates due to the reporting mechanisms used in this study.

02218 is not indicated for adjuvant treatment of colon cancer. The link you ggo selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. ORR by chemotherapy cohort. The GOG study included a diverse population of women [ 1 ].

  CALDO BRILA PDF

Do not administer Avastin for at least 28 days after surgery and until the wound is fully healed Discontinue in patients with wound healing complications requiring medical intervention Hemorrhage Severe or fatal hemorrhage have occurred Do not administer Avastin to patients with serious hemorrhage or recent history of hemoptysis Discontinue for Grade hemorrhage.

Summary of efficacy data from Avastin pivotal trials. In patients receiving Avastin with lomustine, the adverse reaction profile was similar to that observed in other approved indications.

Objective response rate ORR: Dosing and Usage Doses and Duration. The number of patients with measurable disease at baseline was in the Avastin plus chemotherapy arm and in the chemotherapy alone arm Median OS: Genentech does not recommend and does not endorse the content on any third-party 028. Stage III or IV ovarian cancer OC after primary surgery Avastin, in combination with carboplatin and paclitaxel, followed by Avastin as a single agent, is indicated for the treatment of patients with stage III or IV epithelial ovarian, fallopian tube, or primary peritoneal cancer following initial surgical resection.

Click “OK” if you are a healthcare professional.

Recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer rOC Avastin, in combination with goh, pegylated liposomal doxorubicin, or topotecan, is indicated for the treatment of patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who received no more than 2 prior chemotherapy regimens. Efficacy data overview in ITT population [ 1 ].

Median OS by chemotherapy cohort. Your email has been sent!

Bevacizumab Approved by FDA to Treat Ovarian Cancer Following Surgery

Vog completion of indicated cycles of combination therapy, Avastin is indicated for continued use as a single agent until disease progression in patients with platinum-sensitive recurrent ovarian cancer. Recommended dosing for approved cancer types.

  FOSCA UGO TARCHETTI PDF

Recurrent Glioblastoma GBM Avastin is indicated for the treatment of recurrent glioblastoma in adults. Efficacy data overview [ 1 ]. Study design and patient population [ 1,54 ]. Pregnancy warning Based on the mechanism of action and animal studies, Avastin may cause fetal harm Advise female patients that Avastin may cause fetal harm, and to inform their healthcare provider of a known or suspected pregnancy Advise females of reproductive vog to use effective contraception during treatment with Avastin and for 6 months after the last dose of Avastin Advise nursing women that breastfeeding is not recommended during treatment with Avastin and for 6 months following their last dose of treatment Avastin may impair fertility.

Thanks for sharing this page.

Cohort analysis was exploratory. Your use of third-party websites 02218 at your own risk and subject to the terms and conditions of use for such sites. The information contained in this section of the site is intended for U.

Do not administer Avastin for at least 28 days after surgery and until the wound is fully healed Discontinue in patients with wound healing complications requiring medical intervention Hemorrhage Severe or fatal hemorrhage, including hemoptysis, GI bleeding, hematemesis, central nervous system hemorrhage, epistaxis, and vaginal bleeding, occurred up to 5-fold more frequently in patients receiving Avastin.

OS results in patients with psOC 2018 have not received more ggog 1 prior chemotherapy regimen [ 1 ] Median overall survival OS: Avastin plus chemotherapy carboplatin and paclitaxel demonstrated a 5.